Abstract
The morphological and histopathological effects of PGE1 infusion for ductus arteriosus were clarified through novel modality XPCT and immunohistochemical analyses, EP4, and LOX expression. Recognition of microstructural changes of ductal tissue induced by extended administration of PGE1 is profound to establish the safety usage of PGE1 for HLHS patients with staged Norwood repair.
You have full access to this open access chapter, Download conference paper PDF
Similar content being viewed by others
Keywords
1 Introduction
Prostaglandin E1 (PGE1) is essential to maintain the ductus arteriosus (DA) in ductal-dependent congenital heart diseases. Recently, relatively long-term administration of PGE1 has become common, especially in patients with hypoplastic left heart syndrome (HLHS). Staged Norwood approach which consists of PGE1 infusion, bilateral pulmonary artery banding and Norwood procedure provided excellent survival benefit. However, microstructural changes in DA after long-term PGE1 administration remain unknown. Therefore, we sought to investigate the features of DA after long-term PGE1 infusion using synchrotron-based X-ray phase contrast tomography (XPCT), a novel modality to inspect biological soft tissue and pathological scrutiny including DA-specific immunostaining.
2 Methods
Seventeen DA tissues from HLHS patients were obtained during the Norwood procedure. The median duration of PGE1 was 48 days (range 3–123). Radiographic microstructural analysis of DA was performed using XPCT at SPring-8 (Hyogo, Japan). Histological changes focused on elastic fiber and smooth muscle formation were evaluated by Elastica van Gieson staining. Expressions of prostaglandin E2 receptor (EP4) and LOX, a cross-linking enzyme that forms insoluble mature elastic fibers, were evaluated by immunohistochemical analyses.
3 Results
The XPCT study showed sclerotic changes in ductal media. There was a significant correlation between the duration of PGE1 infusion and the mass density of ductal media (R: 0.723, p = 0.001). The histological study showed that the duration of PGE1 infusion was positively correlated with the elastic fiber formation (R: 0.795, P = 0.002) and negatively correlated with smooth muscle formation in a disorganized manner (R: –0.83, P < 0.001). EP4 was disappeared in DAs that were administered PGE1 over 20 days. LOX expression was observed in all DAs, especially LOX strongly emerged in specimens where elastic fiber formation was immature.
4 Conclusion
Long-term administration of PGE1 induced disorganized elastogenesis and density growth of the ductal media. In addition, downregulation of EP4 and LOX expression might emphasize this hypothesis. These results suggested that the dosage of PGE1 could be decreased after a definite period of administration.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Open Access This chapter is licensed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.
The images or other third party material in this chapter are included in the chapter's Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the chapter's Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
Copyright information
© 2020 The Author(s)
About this paper
Cite this paper
Iwaki, R. et al. (2020). The Effect of Long-term Administration of Prostaglandin E1 on Morphological Changes in Ductus Arteriosus. In: Nakanishi, T., Baldwin, H., Fineman, J., Yamagishi, H. (eds) Molecular Mechanism of Congenital Heart Disease and Pulmonary Hypertension. Springer, Singapore. https://doi.org/10.1007/978-981-15-1185-1_44
Download citation
DOI: https://doi.org/10.1007/978-981-15-1185-1_44
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-1184-4
Online ISBN: 978-981-15-1185-1
eBook Packages: MedicineMedicine (R0)